Opening for B.Pharm/M.Pharm in Production, DRA, QC at Saudi Pharmaceutical | Require Formulator, Regulatory Affair Officer, QC Chemist

by Unknown on Thursday, 25 April 2013

Opening for B.Pharm/M.Pharm in Production, DRA, QC at Saudi Pharmaceutical | Require Formulator, Regulatory Affair Officer, QC Chemist


Opening for B.Pharm/M.Pharm in Production, DRA, QC at Saudi Pharmaceutical | Require Formulator, Regulatory Affair Officer, QC Chemist

Posted: 25 Apr 2013 04:17 AM PDT

Saudi Pharmaceutical Industries first and only of its kind manufacturing veterinary and human drugs in Saudi Arabia.
Saudi Pharmaceutical Industries now manufactures high quality veterinary products and its eminence is compared with European standards. During this short period of time we have not only fulfilled the requirements of Saudi Arabia but also expanded our business to all GCC and number of African countries.

Post: Pharmacist- 3


read more

Walk in for M.Pharm, M.Sc as Jr Research Fellow in University of Calcutta

Posted: 25 Apr 2013 04:12 AM PDT

One Junior Research Fellow is will be required for the project entitled “Enhancement of radiation induced oxidative stress in Human hepatocellular carcinoma cells by Ellagic Acid” funded by University Grants Commission ( For 1 Year, extendable only on evaluation) in the Department of Physiology, University of Calcutta under the supervision of Sanjit Dey, Associate Professor, Department of Physiology.
Date of Walk-in interview is on 29.04.2013 at 1 PM in the office of the Development and Planning Officer, 2nd Floor of Dwarbangha Building, (College Street Campus), University of Calcutta, 87/1 College Street, Kolkata 700 073.


read more

Fresh B.Pharm, M.Pharm invited for walk in @ Gebbs Healthcare

Posted: 25 Apr 2013 04:09 AM PDT

GeBBS is a leading provider of healthcare Business Process Outsourcing services to Healthcare Providers (Medical Billing companies, Hospitals, Faculty Practices, ASC’s, LTC’s, etc.) and Pharmacies. We help our clients succeed by leveraging on our domain expertise and technology platforms along with our cost effective approach to global outsourcing.


read more

Job as Phlebotomist in Pragati Diagnostic Centre

Posted: 25 Apr 2013 04:07 AM PDT

Pragati Diagnostic Centre
ours is a joint venture with grand pharmacy and is a collection centre for blood and other testing

Post: Phlebotomist


Job Description:
experienced phlebotomist for proper blood collection and sampling
must be atleast one year experienced


read more

Walk in interview from Junior Research Fellow in University of Calcutta

Posted: 25 Apr 2013 04:05 AM PDT

One Junior Research Fellow will be required in the Department of Physiology, University of Calcutta for the project entitled “Beneficial effect of Tea Extract against Smokeless Tobacco induced oral mucosal damage: Toxicological assessment”. The research fellowship is initially for one year, extendable only on evaluation.

Post: Junior Research Fellow



read more

Opportunity for Nutritionist in Reputed pharma client of Nextus Solutions

Posted: 25 Apr 2013 04:02 AM PDT

Reputed pharma client of Nextus Solutions

Post: Nutritionist, Mumbai



read more

Applications are invited for one post of Senior Research Fellow in Sikkim University

Posted: 25 Apr 2013 04:01 AM PDT

Applications are invited for one post of Senior Research Fellow (SRF) to work under the project entitled “Development and Characterization of Microsatellite markers in M. pruriens- A medicinally and agronomically important legume spp.” funded by the Department of Biotechnology, Govt. of India.

Post: Senior Research Fellow


read more

SUB-ACUTE HEPATO TOXICITY OF TAMOXIFEN CITRATE

Posted: 25 Apr 2013 03:49 AM PDT

About Author:
Zehira Nazir
Master’s In Clinical Biochemistry
University Of Kashmir
zzehra275@gmail.com

Introduction
There has been increasing public concern that chemicals in the environment are affecting human health by disrupting normal endocrine function. The exposure to these chemicals with steroid-like activity can disrupt normal endocrine function leading to altered reproductive capacity, infertility, endometriosis and breast and uterine cancer. In order to detect and evaluate the safety of such chemicals, several rodent experimental models have been developed. The OECD Enhanced Test Guideline 407 (repeated 28-day oral dose toxicity study) is one of rodent experimental models for detection of endocrine disrupters of these chemicals [1].

In recent years, the development of bioassays to detect chemicals that have the potential to interfere with the endocrine system has become a major task in toxicology. One initiative in this direction that was taken on by the OECD (Organization for Economic Co-operation and Development) was to assess the potential of an enhanced version of the sub acute rodent OECD Test Guideline 407 (OECD 1995) to detect endocrine disrupters acting through various mechanisms of toxicity [2].


read more

DEVELOPMENT AND VALIDATION OF FIRST ORDER DERIVATIVE METHOD FOR ANALYSIS OF EPERISONE HYDROCHLORIDE AND LORNOXICAM IN SYNTHETIC MIXTURE

Posted: 25 Apr 2013 03:48 AM PDT

ABOUT AUTHORS:
Harshil R. Patel*, Sejal K. Patel
Department of Quality Assurance,
S. K. Patel College of Pharmaceutical Education and Research,
Ganpat University, Ganpat Vidyanagar – 384012, Mehsana, Gujarat, India.
*harshil285@gmail.com

ABSTRACT
The present manuscript describes simple, sensitive, rapid, accurate, precise and economical derivative spectroscopic methodfor the simultaneous determination of Eperisone Hydrochloride(EPE) and Lornoxicam (LOR) in synthetic mixture. Derivative spectroscopy offers a useful approach for the analysis of drugs in mixtures. In this study a first-derivative spectroscopic method was used for simultaneous determination of Eperisone Hydrochloride and Lornoxicam using the zero-crossing technique. The measurements were carried out at wavelengths of 264 nm and 225.2 nm for Eperisone Hydrochloride and Lornoxicam  respectively. The method was found to be linear (r2>0.998) in the range of 2- 30 μg/ml for Eperisone Hydrochloride at 264 nm. The linear correlation was obtained (r2>0.996) in the range of 2-14 μg/ml for Lornoxicam at 225.2 nm. The limit of detection was 0.2565 and 0.235 μg/ml for Eperisone Hydrochloride and Lornoxicam respectively. The limit of quantification was 0.7774 and 0.7121 μg/ml respectively. The method was successfully applied for simultaneous determination of Eperisone Hydrochloride and Lornoxicam in synthetic mixture.


read more

Leave a Reply

Popular Posts